DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic ...

For Investigational Purposes, Nanowear’s app, platform, and server will transmit Dexcom G7 CGM data, offering first-in-the-world, home-based, self-administered, continuous cardiometabolic ...

Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSensetm, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...

For Investigational Purposes, Nanowear’s app, platform, and server will transmit Dexcom G7 CGM data, offering first-in-the-world, home-based, self-administered, continuous cardiometabolic assessments ...

DexCom witnessed a 4% increase in its share price over the past week, as the company announced a significant integration of its G7 Continuous Glucose Monitoring Systems with Nanowear's SimpleSense ...

DexCom (NasdaqGS:DXCM) witnessed a 4% increase in its share price over the past week, as the company announced a significant integration of its G7 Continuous Glucose Monitoring Systems with Nanowear's ...

Meal Ticket, the leading provider of business management solutions for the foodservice industry, announces the addition of Trackmax to their unified platform, creating a single destination for ...

The agreement then was aimed at helping pathologists generate... Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist ...

Nanowear announced that it entered into a partnership with Dexcom to ingest glucose data from its latest continuous glucose ...